Thus, Rhes, together with the RanBP2/RanGAP1/Ubc9 complexes, may aberrantly influence nuclear export pathways in HD, thereby acting as an attractive target for therapeutic interference. The gene discussed is RANBP2; the disease is Huntington disease.